Kelada Minerva MD - Calexico, California 92231

Kelada Minerva MD is categorized under Doctors in Calexico, CA .

Business Name: Kelada Minerva MD
Contact Person: Minerva Kelada
Address: 1001 Blair Avenue, Calexico, California 92231
Phone Number: (760) 357-7867
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Dr Ajanamjot K Greywall - Calexico, CA 92231
Deanza Urg Mdcl Group - Calexico, CA 92231
Hamid Zadeh Md Inc - Calexico, CA 92231
Hamid Zadeh MD - Calexico, CA 92231
Rabinovich Jacob MD - Calexico, CA 92231
Kucher Valentina MD - Calexico, CA 92231
Sleiman Joseph N MD - Calexico, CA 92231
Knapp P MD - Calexico, CA 92231
Estrada Jaime MD - Calexico, CA 92231
Ceja Mario MD - Calexico, CA 92231
Industrial Urgent Care - Calexico, CA 92231
Muzzarelli Uberto T MD - Calexico, CA 92231
Dr Medical Supplies Inc - Calexico, CA 92231
Franklin H Dulin Md - Calexico, CA 92231
Ellis James Medical Corp - Calexico, CA 92231
Luz Tristan M D Inc - Calexico, CA 92231
Ravinovich Jacob MD - Calexico, CA 92231
Schaaf Bernard MD - Calexico, CA 92231
Villalon Jr Enrique A MD - Calexico, CA 92231
Rodiles Horacio A MD - Calexico, CA 92231

The company Kelada Minerva MD provides B2C services in the form of Doctors from its single location in California. 1 to 4 employees work for Kelada Minerva MD, and the business now earns $500.000 to $999.999 per annum.

Kelada Minerva MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Kelada Minerva MD, please call Minerva Kelada with the phone number (760) 357-7867 or visit its single location at 1001 Blair Avenue in Calexico, California 92231.

The location of the single location can also be found using the coordinates 32.67753,-115.49073. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.